CFF Path to a Cure Collaborative Research Grant

The Path to a Cure Collaborative Research Grant is the Cystic Fibrosis Foundation's main academic award for CFTR gene repair and replacement. It sits under the foundation's Path to a Cure initiative, which is aimed at the roughly 10% to 15% of people with cystic fibrosis who do not benefit from current CFTR modulators. Awards provide up to $1 million a year in direct costs for as long as three years, with up to $25,000 a year available for an administrative core inside that cap and 12% indirect costs on top. Teams must include two to four principal investigators, meet with program staff before submitting, and bring preliminary data that supports a CFTR repair or replacement strategy. The current cycle uses a November deadline and is submitted through the foundation's grants portal. The strongest applications pair novel CFTR-directed technology with a clear route to repairing or replacing the gene defect, and the foundation gives extra weight to projects that bring new investigators into cystic fibrosis research. It is a competitive, peer-reviewed award for established collaborations built around a tightly defined scientific goal.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.